Jk. Coller et al., ASSOCIATION BETWEEN CYP2C19 GENOTYPE AND PROGUANIL OXIDATIVE POLYMORPHISM, British journal of clinical pharmacology, 43(6), 1997, pp. 659-660
Aims To examine the relationship between proguanil metabolism and the
number of mutations in CYP2C19 by comparing the CYP2C19 genotype and p
roguanil phenotype of 10 subjects. Methods Partial clearance and urina
ry metabolic ratio data were obtained from a previous study of 10 subj
ects [5]. Analysis of CYP2C19 genotypes was performed using PCR amplif
ication followed by restriction endonuclease digestion of genomic DNA
from a blood sample. Results The intrinsic partial clearance of PG to
CG ranged from 0.41-10.11 h(-1), and was related to the number of func
tional CYP2C19 alleles present. Genotypic PMs had metabolic ratios >13
, while genotypic heterozygote EMs had metabolic ratios <9. Conclusion
s Proguanil may be a suitable phenotyping probe for the CYP2C19 geneti
c polymorphism, however the exact antimode of the urinary metabolic ra
tio chosen to separate poor and extensive metabolisers needs further i
nvestigation.